Stable, recombinant ValiScreen® cell line expressing the Purinergic receptor P2Y2, human recombinant in 1321N1 host cells.
Revvity's ValiScreen® cell lines are provided in two vials of frozen cells, each containing ~2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line.
Clonal selection Revvity's ValiScreen cell lines is carried out with receptor binding. High and low expressors are n tested and selected optimal binding and functional response according to receptor specific transduction pathway.
Revvity's ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed commercial use. Contact us using Request More Information button above additional information regarding required documentation.
Assay Validation |
Calcium Fluorescence
|
---|---|
Assay Target Class |
GPCR
|
Assay Target Type |
Cell line
|
Brand |
ValiScreen
|
G-Alpha Natural Receptor |
Gq/G11
|
Host |
1321N1
|
Receptor Type |
Purinergic P2Y
|
Second Messenger Release |
Calcium flux
|
Species |
Human
|
Shipping Conditions |
Shipped in Dry Ice
|
Special Ordering Information |
Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
|
Therapeutic Area |
Inflammation
Metabolic
|
Unit Size |
5 million cells
|